Cleopatra K Mugyenyi1,2, Salenna R Elliott2, Xi Zen Yap2,3, Gaoqian Feng2, Philippe Boeuf2,3, Gregory Fegan1, Faith F H Osier1,2,4, Freya J I Fowkes2,5,6, Marion Avril7, Thomas N Williams1,8, Kevin Marsh1, James G Beeson2,3,9. 1. Kenya Medical Research Institute (KEMRI), Centre for Geographic Medicine, Coast, KEMRI-Wellcome Trust Research Programme, Kilifi. 2. Burnet Institute, Melbourne. 3. Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia. 4. Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Germany. 5. Department of Epidemiology and Preventive Medicine, Monash University. 6. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia. 7. Centre for Infectious Disease Research, Seattle, Washington. 8. Imperial College, London, United Kingdom. 9. Central Clinical School and Department of Microbiology, Monash University, Melbourne, Victoria, Australia.
Abstract
Background: We investigated the poorly understood impact of declining malaria transmission on maintenance of antibodies to Plasmodium falciparum merozoite antigens and infected erythrocytes (IEs), including functional immunity. Methods: In a 3-year longitudinal cohort of 300 Kenyan children, antibodies to different AMA1 and MSP2 alleles of merozoites, IE surface antigens, and antibody functional activities were quantified. Results: Over a period in which malaria transmission declined markedly, AMA1 and MSP2 antibodies decreased substantially; estimated half-lives of antibody duration were 0.8 year and 1-3 years, respectively. However, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 alleles. Levels and prevalence of antimerozoite antibodies were consistently associated with increasing age and concurrent parasitemia. Antibodies promoting opsonic phagocytosis of merozoites declined rapidly (half-life, 0.15 years). In contrast, complement-fixing antibodies to merozoites did not decline and antibodies to IE surface antigens expressing virulent phenotypes were much better maintained (half-life, 4-10 years). Conclusions: A decline in malaria transmission is associated with reduction in naturally acquired immunity. However, loss of immunity is not universal; some key functional responses and antibodies to IEs were better maintained and these may continue to provide some protection. Findings have implications for malaria surveillance and control measures and informing vaccine development.
Background: We investigated the poorly understood impact of declining malaria transmission on maintenance of antibodies to Plasmodium falciparum merozoite antigens and infected erythrocytes (IEs), including functional immunity. Methods: In a 3-year longitudinal cohort of 300 Kenyan children, antibodies to different AMA1 and MSP2 alleles of merozoites, IE surface antigens, and antibody functional activities were quantified. Results: Over a period in which malaria transmission declined markedly, AMA1 and MSP2 antibodies decreased substantially; estimated half-lives of antibody duration were 0.8 year and 1-3 years, respectively. However, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 alleles. Levels and prevalence of antimerozoite antibodies were consistently associated with increasing age and concurrent parasitemia. Antibodies promoting opsonic phagocytosis of merozoites declined rapidly (half-life, 0.15 years). In contrast, complement-fixing antibodies to merozoites did not decline and antibodies to IE surface antigens expressing virulent phenotypes were much better maintained (half-life, 4-10 years). Conclusions: A decline in malaria transmission is associated with reduction in naturally acquired immunity. However, loss of immunity is not universal; some key functional responses and antibodies to IEs were better maintained and these may continue to provide some protection. Findings have implications for malaria surveillance and control measures and informing vaccine development.
Authors: Jo-Anne Chan; Danielle I Stanisic; Michael F Duffy; Leanne J Robinson; Enmoore Lin; James W Kazura; Christopher L King; Peter M Siba; Freya Ji Fowkes; Ivo Mueller; James G Beeson Journal: Eur J Immunol Date: 2017-09-13 Impact factor: 5.532
Authors: Danielle I Stanisic; Freya J I Fowkes; Melanie Koinari; Sarah Javati; Enmoore Lin; Benson Kiniboro; Jack S Richards; Leanne J Robinson; Louis Schofield; James W Kazura; Christopher L King; Peter Zimmerman; Ingrid Felger; Peter M Siba; Ivo Mueller; James G Beeson Journal: Infect Immun Date: 2014-11-24 Impact factor: 3.441
Authors: Michelle J Boyle; Linda Reiling; Gaoqian Feng; Christine Langer; Faith H Osier; Harvey Aspeling-Jones; Yik Sheng Cheng; Janine Stubbs; Kevin K A Tetteh; David J Conway; James S McCarthy; Ivo Muller; Kevin Marsh; Robin F Anders; James G Beeson Journal: Immunity Date: 2015-03-17 Impact factor: 31.745
Authors: Faith Ha Osier; Gaoqian Feng; Michelle J Boyle; Christine Langer; Jingling Zhou; Jack S Richards; Fiona J McCallum; Linda Reiling; Anthony Jaworowski; Robin F Anders; Kevin Marsh; James G Beeson Journal: BMC Med Date: 2014-07-01 Impact factor: 8.775
Authors: Freya J I Fowkes; Rose McGready; Nadia J Cross; Mirja Hommel; Julie A Simpson; Salenna R Elliott; Jack S Richards; Kurt Lackovic; Jacher Viladpai-Nguen; David Narum; Takafumi Tsuboi; Robin F Anders; François Nosten; James G Beeson Journal: J Infect Dis Date: 2012-09-10 Impact factor: 5.226
Authors: Linda M Murungi; Gathoni Kamuyu; Brett Lowe; Philip Bejon; Michael Theisen; Samson M Kinyanjui; Kevin Marsh; Faith H A Osier Journal: Vaccine Date: 2013-06-22 Impact factor: 3.641
Authors: Christopher Sundling; Caroline Rönnberg; Victor Yman; Muhammad Asghar; Peter Jahnmatz; Tadepally Lakshmikanth; Yang Chen; Jaromir Mikes; Mattias N Forsell; Klara Sondén; Adnane Achour; Petter Brodin; Kristina Em Persson; Anna Färnert Journal: JCI Insight Date: 2019-04-02
Authors: Damian A Oyong; Danny W Wilson; Bridget E Barber; Timothy William; Jianlin Jiang; Mary R Galinski; Freya J I Fowkes; Matthew J Grigg; James G Beeson; Nicholas M Anstey; Michelle J Boyle Journal: J Infect Dis Date: 2019-11-06 Impact factor: 5.226
Authors: Lotus L van den Hoogen; Gillian Stresman; Jacquelin Présumé; Ithamare Romilus; Gina Mondélus; Tamara Elismé; Alexandre Existe; Karen E S Hamre; Ruth A Ashton; Thomas Druetz; Vena Joseph; James G Beeson; Susheel K Singh; Jacques Boncy; Thomas P Eisele; Michelle A Chang; Jean F Lemoine; Kevin K A Tetteh; Eric Rogier; Chris Drakeley Journal: Front Immunol Date: 2020-05-15 Impact factor: 7.561
Authors: Patricia Njuguna; Kathryn Maitland; Amek Nyaguara; Daniel Mwanga; Polycarp Mogeni; Neema Mturi; Shebe Mohammed; Gabriel Mwambingu; Caroline Ngetsa; Kenedy Awuondo; Brett Lowe; Ifedayo Adetifa; J Anthony G Scott; Thomas N Williams; Sarah Atkinson; Faith Osier; Robert W Snow; Kevin Marsh; Benjamin Tsofa; Norbert Peshu; Mainga Hamaluba; James A Berkley; Charles R J Newton; John Fondo; Anisa Omar; Philip Bejon Journal: BMC Med Date: 2019-07-08 Impact factor: 8.775
Authors: M J Boyle; J A Chan; I Handayuni; L Reiling; G Feng; A Hilton; L Kurtovic; D Oyong; K A Piera; B E Barber; T William; D P Eisen; G Minigo; C Langer; D R Drew; F de Labastida Rivera; F H Amante; T N Williams; S Kinyanjui; K Marsh; D L Doolan; C Engwerda; F J I Fowkes; M J Grigg; I Mueller; J S McCarthy; N M Anstey; J G Beeson Journal: Sci Adv Date: 2019-09-25 Impact factor: 14.136
Authors: Christine N L Wanjala; Elke Bergmann-Leitner; Hoseah M Akala; Geoffrey Odhiambo; Bernhards R Ogutu; Ben Andagalu; Edwin Kamau; Daniel Ochiel Journal: Malar J Date: 2020-04-29 Impact factor: 2.979
Authors: Liriye Kurtovic; Michelle J Boyle; D Herbert Opi; Alexander T Kennedy; Wai-Hong Tham; Linda Reiling; Jo-Anne Chan; James G Beeson Journal: Immunol Rev Date: 2019-09-26 Impact factor: 12.988
Authors: Eric Rogier; Doug Nace; Pedro R Dimbu; Brian Wakeman; Jan Pohl; James G Beeson; Chris Drakeley; Kevin Tetteh; Mateusz Plucinski Journal: Front Immunol Date: 2021-03-02 Impact factor: 7.561
Authors: Katherine O'Flaherty; Win Han Oo; Sophie G Zaloumis; Julia C Cutts; Kyaw Zayar Aung; Myat Mon Thein; Damien R Drew; Zahra Razook; Alyssa E Barry; Naanki Parischa; Nyi Nyi Zaw; Htin Kyaw Thu; Aung Thi; Wai Yan Min Htay; Aung Paing Soe; Julie A Simpson; James G Beeson; Paul A Agius; Freya J I Fowkes Journal: BMC Med Date: 2021-05-28 Impact factor: 8.775